Odoxil DS 250mg Syrup contains Cefadroxil 250mg, a first-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and some Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and pharyngitis caused by susceptible organisms. Cefadroxil acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The syrup formulation facilitates ease of administration, particularly in pediatric and geriatric patients who may have difficulty swallowing tablets. Dosage should be determined based on the severity of infection, patient age, weight, and renal function, with typical dosing ranging from 25 to 50 mg/kg/day divided into two doses. Odoxil DS 250mg Syrup is generally well tolerated; however, adverse effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and hypersensitivity reactions including rash and urticaria. It is contraindicated in patients with known hypersensitivity to cephalosporins or penicillins. Caution is advised in patients with renal impairment, and dose adjustment may be necessary. As with all antibiotics, it is essential to complete the prescribed course to prevent resistance development. Consultation with a healthcare professional is recommended before initiating therapy.